A rationally designed peptide enhances homologous recombination in vitro and resistance to DNA damaging agents in vivo

被引:0
|
作者
Chen, Li-Tzu [1 ,2 ]
Wang, Andrew H. -J. [1 ,2 ]
机构
[1] Natl Taiwan Univ, Inst Biochem Sci, Taipei 106, Taiwan
[2] Acad Sinica, Inst Biol Chem, Taipei 115, Taiwan
关键词
ESCHERICHIA-COLI RECA; N-TERMINAL DOMAIN; CRYSTAL-STRUCTURES; HELICAL FILAMENTS; COMPLEX-FORMATION; RAD51; PROTEIN; DMC1; REPAIR; STABILIZATION;
D O I
10.1093/nar/gkq182
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The RecA family of proteins is essential in homologous recombination, a critical step in DNA repair. Here, we report that a rationally-designed small peptide based on the crystal structure of Escherichia coli RecA-DNA complex can promote homologous recombination through the enhancement of both RecA-mediated strand assimilation and three-strand exchange activity. Among 17 peptides tested, peptide #3 with the amino acid sequence of IRFLTARRR has the most potent activity in promoting the RecA-mediated D-loop formation by similar to 7.2-fold at 37 degrees C. Other peptides such as IRFLTAKKK and IRLLTARRR also have similar, albeit lower, activities. Therefore, hydrophobicity and poly-positive charges, and the space between them in those small peptides are crucial features for such activities. The enhancement of recombination by these peptides appears to be a general phenomenon as similar results were seen by using different plasmids. Remarkably, peptide #3 alone without RecA can also promote the D-loop formation at elevated temperature. Cell viability assays showed that the peptide elevates mammalian cell resistance to two cytotoxic DNA drugs, cisplatin and doxorubicin. The rescue of viability may result from increased DNA repair efficiency. Such peptides may find future biological applications.
引用
收藏
页码:4361 / 4371
页数:11
相关论文
共 50 条
  • [11] HIGH ABSOLUTE FREQUENCY OF HOMOLOGOUS RECOMBINATION IN-VITRO AND IN-VIVO
    TEMPLETON, NS
    BALTRUCKI, L
    GORMAN, CM
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 175 - 175
  • [12] Defects in homologous recombination repair genes are associated with good prognosis and clinical sensitivity to DNA-damaging agents in pancreatic cancer: A case report
    Sonnenblick, Amir
    Zick, Aviad
    Maoz, Myriam
    Cohen, Sherri
    Kadouri, Luna
    Peretz, Tamar
    Hubert, Ayala
    MOLECULAR AND CLINICAL ONCOLOGY, 2018, 8 (05) : 683 - 685
  • [13] Upregulated homologous recombination upon loss of p53 function dose not improve cell survival following treatment with DNA damaging agents
    Willers, H
    Feng, Z
    Bouffard, KE
    Powell, SN
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S459 - S459
  • [14] Sustained in vivo cardiac protection by a rationally designed peptide that causes ε protein kinase C translocation
    Dorn, GW
    Souroujon, MC
    Liron, T
    Chen, CH
    Gray, MO
    Zhou, HZ
    Csukai, M
    Wu, GY
    Lorenz, JN
    Mochly-Rosen, D
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) : 12798 - 12803
  • [15] Silencing of the type 1 insulin-like growth factor receptor (IGF1R) gene enhances sensitivity of prostate cancer to DNA damaging agents through impaired homologous recombination
    Rochester, MA
    Brewster, S
    Macaulay, V
    JOURNAL OF UROLOGY, 2005, 173 (04): : 65 - 66
  • [16] Harnessing homologous recombination in vitro to generate recombinant DNA via SLIC
    Li, Mamie Z.
    Elledge, Stephen J.
    NATURE METHODS, 2007, 4 (03) : 251 - 256
  • [17] Harnessing homologous recombination in vitro to generate recombinant DNA via SLIC
    Li M.Z.
    Elledge S.J.
    Nature Methods, 2007, 4 (3) : 251 - 256
  • [18] Cancer Cells Upregulate Tau to Gain Resistance to DNA Damaging Agents
    Rico, Thomas
    Denechaud, Marine
    Caillierez, Raphaelle
    Comptdaer, Thomas
    Adriaenssens, Eric
    Buee, Luc
    Lefebvre, Bruno
    CANCERS, 2023, 15 (01)
  • [19] DNA-Damaging Therapies in Patients With Prostate Cancer and Pathogenic Alterations in Homologous Recombination Repair Genes
    Graham, Laura S.
    Henderson, Nicholas C.
    Kellezi, Olesia
    Hwang, Clara
    Barata, Pedro C.
    Bilen, Mehmet A.
    Kilari, Deepak
    Pierro, Michael
    Thapa, Bicky
    Tripathi, Abhishek
    Mo, George
    Labriola, Matthew
    Park, Joseph J.
    Rothstein, Shoshana
    Garje, Rohan
    Koshkin, Vadim S.
    Patel, Vaibhav G.
    Dorff, Tanya
    Armstrong, Andrew J.
    McKay, Rana R.
    Alva, Ajjai
    Schweizer, Michael T.
    JCO PRECISION ONCOLOGY, 2024, 8
  • [20] Inhibiting translesion DNA synthesis as an approach to combat drug resistance to DNA damaging agents
    Choi, Jung-Suk
    Kim, Seol
    Motea, Edward
    Berdis, Anthony
    ONCOTARGET, 2017, 8 (25) : 40804 - 40816